Brecon Appoints New Board Director
Leading pharmaceutical outsource services provider Brecon Pharmaceuticals has appointed Dr Susan Miles to its board as Director, Clinical Trials Services.
Dr Sue Miles has been appointed to the Board of Brecon Pharmaceuticals as Director, Clinical Trials Services.
Sue Miles, who joined Brecon in February 2004, is a graduate from Cambridge University with a PhD from the Faculty of Medicine at
Edinburgh University. She was previously Chief Executive Officer of Quantum Research UK, which provides electrocardiography,
respiratory and blood pressure monitoring support for the clinical trials industry.
29 Sep 2021
Back to News Articles